Labiotech.eu

News and Trends 19 Dec 2017

Giving Molecular Combing the Golden Coat It Deserves

The novel spin given to some traditional and established technologies can be astounding. They might have been around for decades, applied in the same way over and over again, and yet, at some point, somebody comes along, observes it in a new light and gives it a brand new polish. One such technology is called […]

December 19, 2017 - 5 minutesmins - By External Contributor

Best in Biotech 19 Dec 2017

Labiotech’s Favorite Biotechs: Which companies do we like and why?

We’ve already named the best companies of the year, but which are our favorite companies? Here’s who they are and why! We tried to be objective when we went through the best companies (as well as the best and worst clinical moments) of the year, but we still have our soft spots. When I asked the […]

December 19, 2017 - 4 minutesmins - By Evelyn Warner

granulomatous disease orchard therapeutics

News and Trends 18 Dec 2017

British Biotech Takes Over Development of Gene Therapy for Rare Immune Disease

Orchard Therapeutics has licensed a gene therapy for the rare genetic disorder X-linked chronic granulomatous disease (X-CGD) from the non-profit Généthon. London-based Orchard Therapeutics is adding a new program to its pipeline of gene therapies. The company has obtained an exclusive license to a lentiviral vector to treat X-linked chronic granulomatous disease and the clinical trial data […]

December 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Dec 2017

Belgian Biotech’s Crohn’s Disease Cell Therapy Gets Recommended for Approval

An EMA committee has supported an allogeneic stem cell therapy for the first time, as TiGenix’s Crohn’s disease candidate is backed for approval. TiGenix and its Japanese partner, Takeda, are developing a stem cell therapy for Crohn’s disease – an autoimmune disease affecting the gastrointestinal tract. This morning, the companies have revealed that their candidate, Cx601, has received the backing […]

December 18, 2017 - 3 minutesmins - By Alex Dale

hpv cancer isa pharmaceuticals regeneron

News and Trends 18 Dec 2017

Dutch and US Biotechs Team Up Against HPV-related Cancer

ISA Pharmaceuticals will work together with Regeneron to combine its immunotherapy against cancer induced by HPV infection with its partner’s PD-1 checkpoint inhibitor. The human papillomavirus (HPV) is known for its ability to cause cancer, including cervical and head and neck cancer. Based in Leiden, the Netherlands, ISA Pharmaceuticals’ target choice is type 16 HPV, which […]

December 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 18 Dec 2017

French Biotech will work with the World’s Leader in Hearing Implants

Sensorion and Cochlear will explore if a combination of a drug and a hearing implant can improve the treatment of hearing loss. Based in the French city of Montpellier, Sensorion specializes in the development of treatments for inner ear disorders such as vertigo and hearing loss. The company’s technology received major recognition today with the […]

December 18, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 18 Dec 2017

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

Now that we’ve got the bad news out of the way, we’re here to spread some Christmas cheer with the biggest clinical successes in biotech over the past 12 months. It’s unlikely that one whole year will ever pass without a single hiccup, especially in a field as complex as biotech. For that reason, we […]

December 18, 2017 - 9 minutesmins - By Alex Dale

News and Trends 16 Dec 2017

Science and Art Join Forces to Challenge our Anthropocentric Worldviews

Western culture seems to revolve exclusively around humans. It seems that we have forgotten the existence and the needs of all other organisms, from microscopic bacteria and fungi that make our food and medicines to the chickens and cows that feed us. But is this anthropocentric behavior justified? What are the consequences of our destructive attitude […]

December 16, 2017 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Dec 2017

Signed, Sealed. Will GW Pharma’s Epilepsy Treatment Be a 2018 Blockbuster?

GW Pharma might be about to join the likes of Genmab in the biotech blockbuster club, with its epilepsy drug predicted to achieve sales of close to $1B in 2018. GW Pharma develops therapies for a range of diseases, including autism, epilepsy and brain cancer using its cannabinoid product platform. In a rundown of the top 10 […]

December 15, 2017 - 2 minutesmins - By Alex Dale

News and Trends 15 Dec 2017

Abivax Spots an Extra Benefit of its Potential HIV Cure

Phase IIa data confirms that Abivax’s potential HIV cure not only reduces viral reservoir but it also has anti-inflammatory effects. Abivax targets the immune system to fight viral infections, including human immunodeficiency virus (HIV), as well as autoimmune diseases. The company has now confirmed the preliminary results from its first cohort of patients in a […]

December 15, 2017 - 2 minutesmins - By Alex Dale

Startup Scout 15 Dec 2017

Czech this Biotech Out! Bioinova Develops Stem Cell Therapies

This week, we are in Prague to visit Bioinova. This biotech develops cell therapies for a wide range of indications, from broken bones to autoimmune diseases. Mission: From bone marrow and adipose (fat) tissue, Bioinova develops stem cell products that can be used for orthopedic, ophthalmological, neurological, and autoimmune indications, as well as to aid wound healing. […]

December 15, 2017 - 2 minutesmins - By Alex Dale

News and Trends 14 Dec 2017

The FDA Fast Tracks Therapy for Rare Disease Causing Copper Accumulation

The FDA is speeding up the process for regulatory approval of WTX101, a therapy for Wilson’s disease that could significantly improve the standard of care. Wilson Therapeutics, in Stockholm, has convinced the FDA to include its drug WTX101 (bis-choline tetrathiomolybdate) in its Fast Track program. This move will speed up the approval of the drug, […]

December 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Giving Molecular Combing the Golden Coat It Deserves

Labiotech’s Favorite Biotechs: Which companies do we like and why?

British Biotech Takes Over Development of Gene Therapy for Rare Immune Disease

Belgian Biotech’s Crohn’s Disease Cell Therapy Gets Recommended for Approval

Dutch and US Biotechs Team Up Against HPV-related Cancer

French Biotech will work with the World’s Leader in Hearing Implants

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

Science and Art Join Forces to Challenge our Anthropocentric Worldviews

Signed, Sealed. Will GW Pharma’s Epilepsy Treatment Be a 2018 Blockbuster?

Abivax Spots an Extra Benefit of its Potential HIV Cure

Czech this Biotech Out! Bioinova Develops Stem Cell Therapies

The FDA Fast Tracks Therapy for Rare Disease Causing Copper Accumulation

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!